Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 1
1994 1
1995 5
1996 13
1997 28
1998 56
1999 81
2000 104
2001 156
2002 182
2003 261
2004 314
2005 396
2006 431
2007 404
2008 482
2009 416
2010 453
2011 506
2012 467
2013 417
2014 449
2015 401
2016 385
2017 347
2018 351
2019 331
2020 301
2021 277
2022 243
2023 250
2024 105

Search Results

7,618 results

Results by year

Filters applied: . Clear all
Page 1
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
Neilan TG, Quinaglia T, Onoue T, Mahmood SS, Drobni ZD, Gilman HK, Smith A, Heemelaar JC, Brahmbhatt P, Ho JS, Sama S, Svoboda J, Neuberg DS, Abramson JS, Hochberg EP, Barnes JA, Armand P, Jacobsen ED, Jacobson CA, Kim AI, Soumerai JD, Han Y, Friedman RS, Lacasce AS, Ky B, Landsburg D, Nasta S, Kwong RY, Jerosch-Herold M, Redd RA, Hua L, Januzzi JL, Asnani A, Mousavi N, Scherrer-Crosbie M. Neilan TG, et al. JAMA. 2023 Aug 8;330(6):528-536. doi: 10.1001/jama.2023.11887. JAMA. 2023. PMID: 37552303 Free PMC article. Clinical Trial.
Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway.
Ning Y, Huang P, Chen G, Xiong Y, Gong Z, Wu C, Xu J, Jiang W, Li X, Tang R, Zhang L, Hu M, Xu J, Xu J, Qian H, Jin C, Yang Y. Ning Y, et al. BMC Med. 2023 Mar 16;21(1):96. doi: 10.1186/s12916-023-02778-x. BMC Med. 2023. PMID: 36927608 Free PMC article.
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial.
Kronborg TM, Schierwagen R, Trošt K, Gao Q, Moritz T, Bendtsen F, Gantzel RH, Andersen ML, Teisner AS, Grønbæk H, Hobolth L, Møller S, Trebicka J, Kimer N. Kronborg TM, et al. Hepatol Commun. 2023 Dec 1;7(12):e0332. doi: 10.1097/HC9.0000000000000332. eCollection 2023 Dec 1. Hepatol Commun. 2023. PMID: 38051553 Free PMC article. Clinical Trial.
Atorvastatin-induced acute cholestatic hepatitis.
Maroto-Martín C, Molina Terrón PM, García Pajares F. Maroto-Martín C, et al. Med Clin (Barc). 2022 Dec 9;159(11):e77-e78. doi: 10.1016/j.medcli.2022.07.013. Epub 2022 Aug 25. Med Clin (Barc). 2022. PMID: 36030096 English, Spanish. No abstract available.
Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial.
Yunihastuti E, Rusdi L, Syahrir Azizi M, Estiasari R, Jasirwan COM, Wulandari EAT, Purnamasari D, Shinta Noviar M, Aman Nasution S. Yunihastuti E, et al. F1000Res. 2023 Sep 15;10:151. doi: 10.12688/f1000research.28262.2. eCollection 2021. F1000Res. 2023. PMID: 37772075 Free PMC article. Clinical Trial.
7,618 results